Michael C. Fiore
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michael C. Fiore has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Timothy B. Baker
Michael C. Fiore and Timothy B. Baker are with the Center for Tobacco Research and Intervention, School of Medicine and Public Health, University of Wisconsin, Madison
3 shared publicationsPaula A. Keller
University of Wisconsin Center for Tobacco Research and Intervention, Madison, Wisconsin
2 shared publications- Paula A. Keller
University of Wisconsin Center for Tobacco Research and Intervention, Madison, Wisconsin, USA
2 shared publications Susan J. Curry
Institute for Health Research and Policy, University of Illinois–Chicago, Chicago, Illinois
2 shared publications- Bruce A. Christiansen
Paula A. Keller, MPH; Bruce Christiansen, PhD; Su-Young Kim, MS; Megan E. Piper, PhD; Lezli Redmond, MPH; Robert Adsit, MEd; and Michael C. Fiore, MD, MPH, MBA are with the University of Wisconsin Center for Tobacco Research and Intervention, Madison, Wisconsin
1 shared publication C. Tracy Orleans
1 shared publication
Latest Publications
- 1 July 2011
- Published by SAGE Publications in American Journal of Health Promotion
- Vol. 25 (6) , 392-395
Increasing Consumer Demand among Medicaid Enrollees for Tobacco Dependence Treatment: The Wisconsin “Medicaid Covers It” Campaign
Purpose.: Smoking prevalence among Medicaid enrollees is higher than among the general population, but use of evidence-based cessation treatment is low. We evaluated whether a communications campaign improved cessation treatment utilization. Design.: Quasi-experimental. Setting.: Wisconsin. Subjects.: Enrollees in the Wisconsin Family Medicaid program. The average monthly enrollment during the study period was approximately 170,000 individuals. Intervention.: Print materials for clinicians and consumers distributed to 13 health maintenance organizations (HMOs) serving Wisconsin Medicaid HMO enrollees. Measures.: Wisconsin Medicaid pharmacy claims data for smoking cessation medications were analyzed before and after a targeted communications campaign. HMO enrollees were the intervention group. Fee-for-service enrollees were a quasi-experimental comparison group. Quit Line utilization data were also analyzed. Analysis.: Pharmacotherapy claims and number of registered Quit Line callers were compared precampaign and postcampaign. Results.: Precampaign, cessation pharmacotherapy claims declined for the intervention group and increased slightly for the comparison group (t = 2.29, p = .03). Postcampaign, claims increased in both groups. However, the rate of increase in the intervention group was significantly greater than in the comparison group (t = −2.2, p = .04). A statistically significant increase was also seen in the average monthly number of Medicaid enrollees that registered for Quit Line services postcampaign compared to precampaign (F [1,22] = 7.19, p = .01). Conclusion.: This natural experiment demonstrated statistically significant improvements in both pharmacotherapy claims and Quit Line registrations among Medicaid enrollees. These findings may help inform other states' efforts to improve cessation treatment utilization.
- 1 July 2011
- Published by SAGE Publications in American Journal of Health Promotion
- Vol. 25 (6) , 392-395
Increasing Consumer Demand among Medicaid Enrollees for Tobacco Dependence Treatment: The Wisconsin “Medicaid Covers It” Campaign
Purpose.: Smoking prevalence among Medicaid enrollees is higher than among the general population, but use of evidence-based cessation treatment is low. We evaluated whether a communications campaign improved cessation treatment utilization. Design.: Quasi-experimental. Setting.: Wisconsin. Subjects.: Enrollees in the Wisconsin Family Medicaid program. The average monthly enrollment during the study period was approximately 170,000 individuals. Intervention.: Print materials for clinicians and consumers distributed to 13 health maintenance organizations (HMOs) serving Wisconsin Medicaid HMO enrollees. Measures.: Wisconsin Medicaid pharmacy claims data for smoking cessation medications were analyzed before and after a targeted communications campaign. HMO enrollees were the intervention group. Fee-for-service enrollees were a quasi-experimental comparison group. Quit Line utilization data were also analyzed. Analysis.: Pharmacotherapy claims and number of registered Quit Line callers were compared precampaign and postcampaign. Results.: Precampaign, cessation pharmacotherapy claims declined for the intervention group and increased slightly for the comparison group (t = 2.29, p = .03). Postcampaign, claims increased in both groups. However, the rate of increase in the intervention group was significantly greater than in the comparison group (t = −2.2, p = .04). A statistically significant increase was also seen in the average monthly number of Medicaid enrollees that registered for Quit Line services postcampaign compared to precampaign (F [1,22] = 7.19, p = .01). Conclusion.: This natural experiment demonstrated statistically significant improvements in both pharmacotherapy claims and Quit Line registrations among Medicaid enrollees. These findings may help inform other states' efforts to improve cessation treatment utilization.
- 1 July 2009
- Published by American Public Health Association in American Journal of Public Health
- Vol. 99 (7) , 1170-1175
Stealing a March in the 21st Century: Accelerating Progress in the 100-Year War Against Tobacco Addiction in the United States
Tobacco use in the United States has declined dramatically over the past 50 years, with the prevalence of cigarette smoking falling from about 42% of all adults to less than 20% by 2007. If this rate of decline continues, smoking could be eliminated in the United States by 2047.Framed in military parlance, we may be halfway through a 100-year war against the leading public health killer of our time. We describe factors that have contributed to progress over the last 50 years and identify policy and other initiatives that can contribute to the elimination of tobacco use in the United States.
- 1 July 2009
- Published by American Public Health Association in American Journal of Public Health
- Vol. 99 (7) , 1170-1175
Stealing a March in the 21st Century: Accelerating Progress in the 100-Year War Against Tobacco Addiction in the United States
Tobacco use in the United States has declined dramatically over the past 50 years, with the prevalence of cigarette smoking falling from about 42% of all adults to less than 20% by 2007. If this rate of decline continues, smoking could be eliminated in the United States by 2047.Framed in military parlance, we may be halfway through a 100-year war against the leading public health killer of our time. We describe factors that have contributed to progress over the last 50 years and identify policy and other initiatives that can contribute to the elimination of tobacco use in the United States.
- Open Access
- 13 January 2009
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 6 (1) , 259-266
Tobacco Cessation Quitline Spending in 2005 and 2006: What State-Level Factors Matter?
Tobacco cessation telephone quitlines are an effective population-wide strategy for smoking cessation, but funding for this service varies widely. State-level factors may explain this difference. Data from the 2005 and 2006 North American Quitline Consortium surveys and from publicly available sources were analyzed to identify factors that predict higher levels of per capita quitline funding. The best-fitting multivariate model comprised higher per capita tobacco control funding (2005 p = 0.004, 2006 p=0.000), not securitizing Master Settlement Agreement payments (2005 p = 0.008, 2006 p=0.01), and liberal political ideology (2005 p = 0.002, 2006 p=0.002). Select state-level factors appear to have influenced per capita quitline services funding. These findings can help inform advocates and policymakers as they advocate for quitlines and tobacco control funding.
- 13 January 2009
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 6 (1) , 259-266
Open AccessTobacco Cessation Quitline Spending in 2005 and 2006: What State-Level Factors Matter?
Tobacco cessation telephone quitlines are an effective population-wide strategy for smoking cessation, but funding for this service varies widely. State-level factors may explain this difference. Data from the 2005 and 2006 North American Quitline Consortium surveys and from publicly available sources were analyzed to identify factors that predict higher levels of per capita quitline funding. The best-fitting multivariate model comprised higher per capita tobacco control funding (2005 p = 0.004, 2006 p=0.000), not securitizing Master Settlement Agreement payments (2005 p = 0.008, 2006 p=0.01), and liberal political ideology (2005 p = 0.002, 2006 p=0.002). Select state-level factors appear to have influenced per capita quitline services funding. These findings can help inform advocates and policymakers as they advocate for quitlines and tobacco control funding.
- 7 May 2008
- Published by American Medical Association (AMA) in JAMA
- Vol. 299 (17) , 2083-2085
A Clinical Blueprint to Accelerate the Elimination of Tobacco Use
Opinion from JAMA — A Clinical Blueprint to Accelerate the Elimination of Tobacco Use
- 7 May 2008
- Published by American Medical Association (AMA) in JAMA
- Vol. 299 (17) , 2083-2085
A Clinical Blueprint to Accelerate the Elimination of Tobacco Use
Opinion from JAMA — A Clinical Blueprint to Accelerate the Elimination of Tobacco Use
- 1 December 2007
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 33 (6) , S349-S356
Health System Changes to Facilitate the Delivery of Tobacco-Dependence Treatment
- 1 December 2007
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 33 (6) , S349-S356
Health System Changes to Facilitate the Delivery of Tobacco-Dependence Treatment
- 1 April 2004
- Published by Elsevier in Preventive Medicine
- Vol. 38 (4) , 412-420
Integrating smoking cessation treatment into primary care: an effectiveness study
- 1 April 2004
- Published by Elsevier in Preventive Medicine
- Vol. 38 (4) , 412-420
Integrating smoking cessation treatment into primary care: an effectiveness study
- 1 February 2004
- Published by American Public Health Association in American Journal of Public Health
- Vol. 94 (2) , 205-210
Preventing 3 Million Premature Deaths and Helping 5 Million Smokers Quit: A National Action Plan for Tobacco Cessation
In August 2002, the Subcommittee on Cessation of the Interagency Committee on Smoking and Health (ICSH) was charged with developing recommendations to substantially increase rates of tobacco cessation in the United States. The subcommittee’s report, A National Action Plan for Tobacco Cessation, outlines 10 recommendations for reducing premature morbidity and mortality by helping millions of Americans stop using tobacco. The plan includes both evidence-based, population-wide strategies designed to promote cessation (e.g., a national quitline network) and a Smokers’ Health Fund to finance the programs (through a $2 per pack excise tax increase). The subcommittee report was presented to the ICSH (February 11, 2003), which unanimously endorsed sending it to Secretary Thompson for his consideration. In this article, we summarize the national action plan.
- 1 February 2004
- Published by American Public Health Association in American Journal of Public Health
- Vol. 94 (2) , 205-210
Preventing 3 Million Premature Deaths and Helping 5 Million Smokers Quit: A National Action Plan for Tobacco Cessation
In August 2002, the Subcommittee on Cessation of the Interagency Committee on Smoking and Health (ICSH) was charged with developing recommendations to substantially increase rates of tobacco cessation in the United States. The subcommittee’s report, A National Action Plan for Tobacco Cessation, outlines 10 recommendations for reducing premature morbidity and mortality by helping millions of Americans stop using tobacco. The plan includes both evidence-based, population-wide strategies designed to promote cessation (e.g., a national quitline network) and a Smokers’ Health Fund to finance the programs (through a $2 per pack excise tax increase). The subcommittee report was presented to the ICSH (February 11, 2003), which unanimously endorsed sending it to Secretary Thompson for his consideration. In this article, we summarize the national action plan.
- 9 October 2002
- Published by American Medical Association (AMA) in JAMA
- Vol. 288 (14) , 1768-1771
Effective Tobacco Dependence Treatment
More than at any time in the past, clinicians, public health professionals, and policy makers now possess sufficient evidence to implement effective tobacco d
- 9 October 2002
- Published by American Medical Association (AMA) in JAMA
- Vol. 288 (14) , 1768-1771
Effective Tobacco Dependence Treatment
More than at any time in the past, clinicians, public health professionals, and policy makers now possess sufficient evidence to implement effective tobacco d
- Open Access
Treating Tobacco Use and Dependence
- 1 December 1998
- Published by BMJ in Tobacco Control
- Vol. 7 (Supplement) , S14-S16
Overview of the Agency for Health Care Policy and Research guideline
- 1 December 1998
- Published by BMJ in Tobacco Control
- Vol. 7 (Supplement) , S14-S16
Overview of the Agency for Health Care Policy and Research guideline